Equity Research Service

RNS Number : 6026P

Futura Medical PLC

03 October 2013

 



For immediate release

3 October 2013

 

RNS REACH

 

Futura Medical plc

("Futura" or the "Company")

Equity Research Service

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that an equity research service has been added to the investor section of Futura's website and that an initiation of coverage report can be viewed at this link: www.futuramedical.com/archive/research/FuturaMedical021013outlook.pdf

Shareholders or potential shareholders will automatically be notified of any future research reports if they register with the Company's investor alert service at the following link: www.futuramedical.com/content/investors/alert_service.asp

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc
Bobbie Hilliam	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles www.buchanan.uk.com	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NRAUUUAROVARRUA